Ultra-low microcurrent in the management of diabetes mellitus, hypertension and chronic wounds: Report of twelve cases and discussion of mechanism of action

International Journal of Medical Sciences

Volumn 7, Issue 1, 2010, Pages 29-35

  Lee, Bok Y ^a,b   Al Waili, Noori ^b   Stubbs, Dean ^c   Wendell, Keith ^d   Butler, Glenn ^b,d   Al Waili, Thia ^e   Al Waili, Ali ^f  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Mount Vernon Hospital USA   (United States)

^c BodiHealth Technology   (Australia)

^d American Institute of Regeneration   (Australia)

^e American Global University of Medical School   (Belize)

^f CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Diabetes mellitus; Hypertension; Ultra low microcurrent; Wound

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; LISINOPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BOWEN DISEASE; CHRONIC ACTIVE HEPATITIS; CHRONIC PAIN; CHRONIC WOUND; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC DIET; DIABETIC NEUROPATHY; DIRECT CURRENT; DRUG EFFICACY; ELECTRIC CURRENT; ELECTRIC POTENTIAL; ELECTRICITY; FEMALE; FIBROMYALGIA; FOOT AMPUTATION; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE FAILURE; HEPATITIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPONATREMIA; HYPOTHYROIDISM; MALE; NECROTIZING FASCIITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOARTHRITIS; OSTEOMYELITIS; POLARIZATION; POSITIONAL VERTIGO; RHEUMATOID ARTHRITIS; STROKE; TUBERCULOSIS; ULTRA LOW MICROCURRENT; WOUND INFECTION;

EID: 76149092511     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.7.29     Document Type: Article

References (68)

1. Griendling KK, Fitzgerald GA. Oxidative stress and cardiovascular injury. Animal and human studies. Circulation. 2003; 108: 2034-2040.
2. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol. 2005; 25: 29-38.
3. Mueller CFH, Laude K, McNally JS, Harrison DG. Redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol. 2005; 25: 274-278
4. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997; 272: 20963-20966.
5. Wei EP, Kontos HA, Christman CW, DeWitt DS. Superoxide generation and reversal of acetylcholine-induced cerebral arteriolar dilation after acute hypertension. Circ Res. 1985; 57: 781-787.
6. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol: Heart Circ Physiol. 1986; 250: H822-H827
7. Maritim C, Sanders R, Watkins J. Diabetes, oxidative stress, and antioxidants: A review. J Bioch Mol Toxicol, 2003; 17: 24 - 38
8. Baynes J, Thorpe S. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48: 1-9.
9. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414: 813-820.
10. Jakus V. The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease. Bratisl Lek Listy. 2000;101:541-51
11. Bruce CR, Carey AL, Hawley JA, Febbraio MA. Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes. 2003; 52: 2338-2345.
12. Ceriello A, Morocutti A, Mercuri F, Quagliaro L, Moro M, Damante G, Viberti GC. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes. 2000; 49: 2170-2177.
13. Hodgkinson AD, Bartlett T, Oates PJ, Millward BA, Demaine AG. The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes 2003; 52: 846-851
14. Anamika M, Rasik AS. Antioxidant status in delayed healing type of wounds. Inter J Exper Path 2000; 81: 257-263
15. Tim J, James MS, Margaret A. Hughes, George W. Cherry, Richard P. Taylor. Evidence of oxidative stress in chronic venous ulcers. Wound Rep Reg. 1999;11:172-176
16. Paolisso G, Giugliano D. Oxidative stress and insulin action. Is there a relationship? Diabetologia. 1996; 39: 357-363.
17. Sen CK, Khanna S, Gordillo G, Bagchi D, Bagchi M, Roy S. Oxygen, oxidants, and antioxidants in wound healing: an emerging paradigm. Ann N Y Acad Sci. 2002 May;957:239-49
18. Carley, P J, Wainapel, S F. Electrotherapy for acceleration of wound healing: low intensity direct current. Arch Phys Med Rehabil. 1985; 66:443-446.
19. Nessler, JP, Mass DP. Direct-current stimulation of tendon healing in vitro. Clin Orthop 1987; 217:303-312.
20. AL-Waili N. Electrotherapy for chronic gum and periapical abscesses. J Pak Med Assoc. 1989; 39:161-162.
21. Lee BY, Wendell K, AL-Waili N, Butler G. Ultra-low microcurrent therapy: a novel approach for treatment of chronic resistant wounds. Adv Ther 2007;24(6):1202-9.
22. Bach, S, Bilgrav, K, Gottrup, F, Jorgensen, TE. The effect of electrical current on healing skin incision: an experimental study. Eur J Surg 1991; 157:171-174.
23. Carley, P J, Wainapel, S F. Electrotherapy for acceleration of wound healing: low intensity direct current. Arch Phys Med Rehabil. 1985; 66:443-446.
24. Mäenpää, H, Jaakkola, R, Sandström, M, Von Wendt, L. Does microcurrent stimulation increase the range of movement of ankle dorsiflexion in children with cerebral palsy? Disabil Rehabil. 2004; 26:669-677.
25. King, GE, Jacob, RF, Martin, JW. Electrotherapy and hyperbaric oxygen: Promising treatments for postradiation complications. J Prosthetic Dentistry 1989; 62:331-334.
26. Cheng N, Van Hoof H, Bockx E, Hoogmartens MJ, Mulier JC, De Dijcker FJ, Sansen WM, De Loecker W. The effects of electric currents on ATP generation, protein synthesis, and membrane transport of rat skin. Clin Orthop Relat Res 1982;171:264-72.
27. McCaig, D, Rajnicek, M, Song, B, Zhao, M. Has electrical growth cone guidance found its potential? Trends Neurosci 2002; 25: 354-359.
28. Zhao, M, Bai, H, Wang, E, Forrester, V, McCaig, D. Electrical stimulation directly induces pre-angiogenic response in vascular endothelial cells by signaling through VEGF receptors. J Cell Sci 2003; 117: 397-405.
29. Todd, I, Clothier, RH, Huggins, ML, Patel, N, Searle, KC, Jeyarajah, S, Pradel, L, Lacey, KL. Electrical stimulation of transforming growth factor-beta 1 secretion by human dermal fibroblasts and the U937 human monocytic cell line. Altern Lab Anim. 2001; 29:693-701.
30. Petersen KF, Shulman GI. New insights into the pathogenesis of insulin resistance in humans using magnetic resonance spectroscopy. Obesity (Silver Spring) 2006;14 (Suppl 1): 34S-40S.
31. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997;46: 3-10
32. Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005; 7: 1040-1052
33. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes. 2003; 52: 1-8
34. Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H. Glucose toxicity in β-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes. 2003; 52: 581-587
35. Tiedge M, Lortz S, Drinkgern J, Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin producing cells. Diabetes. 1997; 46: 1733-1742.
36. El-Assad W, Buteau J, Peyot ML, Nolan C, Roduit R, Hardy S et al. Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology. 2003; 144: 4154-4163.
37. Piro S, Anello M, Di Pietro C, Lizzio MN, Patane G, Rabuazzo AM, Vigneri R, Purrello M, Purrello F. Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism. 2002; 51: 1340-1347
38. Ceriello A. The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia. 2003; 46: M9-M16.
39. Del Prato S. Loss of early insulin secretion leads to postprandial hyperglycaemia. Diabetologia. 2003; 46: M2-M8.
40. Finkel T, Holbrook NJ: Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408:239-247.
41. Huang H, Manton KG: The role of oxidative damage in mitochondria during aging: a review. Front Biosci 2004; 9:1100-111
42. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404:787-790
43. Jenner P: Parkinson's disease, pesticides and mitochondrial dysfunction. Trends Neurosci 2001; 24:245-247
44. Aliev G, Seyidova D, Lamb BT, Obrenovich ME, Siedlak SL, Vinters HV, Friedland RP, LaManna JC, Smith MA, Perry G: Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice. Neurol Res 2003; 25:665-674
45. Yorek MA: The role of oxidative stress in diabetic vascular and neural disease. Free Radic Res 2003; 37:471-480
46. Schrauwen P, Hesselink MK: Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 2004; 53:1412-1417
47. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414:813-820
48. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M: IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005; 11:191-198
49. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE: Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005; 11:183-190
50. Ho E, Bray TM: Antioxidants, NFkappaB activation, and diabetogenesis. Proc Soc Exp Biol Med 1999; 222:205-213
51. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, Shulman GI: Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001; 108:437-446
52. Evans L. Antioxidants: do they have a role in the management of insulin resistance. Indian J Med Res 2007; 125: 355-375
53. Honjo T, Inane N. Antioxidants drugs as the strategy for treatment of metabolic syndrome. Nippon Rinsho 2006; 28: 660-667
54. Davì G, Ciabottoni G, Consoli A, Messetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, Patrono C. In vivo formation of 8-iso-prostaglandin F2á and platelet activation in diabetes mellitus. effects of improved metabolic control. Circulation. 1999;99: 224-229
55. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000; 87: 840-844
56. Mehta JL, Lopez LM, Chen L, Cox OE. Alterations in nitric oxide synthase activity, superoxide anion generation, and platelet aggregation in systemic hypertension, and effects of celiprolol. Am J Cardiol. 1994; 74: 901-905.
57. Lacy F, O'Connor DT, Schmid-Schonbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens. 1998; 16: 291-303
58. Zalba G, San Jose G, Moreno M, Fortuno M, Fortuno A, Beaumont F, Diez J. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension. 2001; 38: 1395-1399.
59. Nickenig G, Harrison DG. The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis. Circulation. 2002; 105: 393-396
60. Senel O, Cetinkale O, Ozbay G, Ahçioǧlu F, Bulan R. Oxygen free radicals impair wound healing in ischemic rat skin. Ann Plast Surg. 1997;39: 516-23.
61. Foschi D, Trabucchi E, Musazzi M, Castoldi L, Di Mattia D, Radaelli E, Marazzi M, Franzini P, Berlusconi A. The effects of oxygen free radicals on wound healing. Int J Tissue React. 1988;10(6):373-9
62. Ceriello A. Oxidative stress and glycemic regulation. Metabolism. 2000; 49: 27-29.
63. Tesfamariam B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol. 1992; 263: H321-H326.
64. Marfella R, Verrazzo G, Acampora R, La Marca C, Giunta R, Lucarelli C, Paolisso G, Ceriello A, Giugliano D. Glutathione reverses systemic hemodynamic changes by acute hyperglycemia in healthy subjects. Am J Physiol. 1995; 268: E1167-E1173.
65. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1996; 97: 22-28
66. Marchioli R, Schweiger C, Levantesi G, Gavazzi L, Valagussa F. Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data. Lipids. 2001; 36: S53-S63.
67. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev. 2001; 53: 135-159.
68. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "Causal" antioxidant therapy. Diabetes Care. 2003; 26: 1589-1596.